Does pain relief during delivery decrease the risk of postnatal depression?
Pauliina Hiltunen, Tytti Raudaskoski, Hanna Ebeling, Irma Moilanen, Pauliina Hiltunen, Tytti Raudaskoski, Hanna Ebeling, Irma Moilanen
Abstract
Background: To test the hypothesis that sufficient pain relief during delivery decreases the risk of postnatal depression.
Methods: As part of a prospective follow-up study of the risk factors for postnatal depression and its impact on the mother-infant interaction and child development, 185 parturients filled in the Edinburgh Postnatal Depression Scale (EPDS), first during the first postpartum week and again (n = 162) 4 months later. The incidence and the risk of high EPDS scores was calculated according to the mode of delivery and the mode of pain relief during vaginal delivery, also after adjusting for the length of labor.
Results: Mothers who received epidural/paracervical blockade during their delivery spent less time in the delivery room than mothers in the nitrous oxide/acupuncture group (p = 0.033) or mothers with no pain relief (p = 0.026) and had shorter length of labor than mothers without pain relief (p = 0.04). The adjusted risk of depressive scores at the first postnatal week was decreased in the epidural/paracervical group when compared with no analgesia group (OR: 0.25, 95% CI: 0.09-0.72). This difference was not shown at 4 months postpartum. Elective or emergency cesarean section did not increase the risk of high EPDS scores at the first week or at 4 months postpartum.
Conclusion: The mode of pain relief during vaginal delivery seems to be associated with the incidence of postpartum depression, especially immediately after delivery.
Source: PubMed
Prochains essais cliniques
-
University of TennesseeWoodcock Institute for the Advancement of Neurocognitive Research and Applied...Pas encore de recrutementMotricité | En bonne santé | Fonction exécutive
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLCPas encore de recrutementCarcinome épidermoïde anal
-
Universita di VeronaAzienda Ospedaliera Universitaria Integrata VeronaPas encore de recrutementLa polyarthrite rhumatoïde | Maladie articulaire dégénérative du genouItalie
-
University of Wisconsin, MadisonAlkermes, Inc.Pas encore de recrutement
-
Virginia Commonwealth UniversityPas encore de recrutement
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH); Icahn School of Medicine at Mount...Pas encore de recrutementKétamine | IRMf | Dépression - Trouble dépressif majeur | SMTr | Dépression résistante au traitement (TRD)États-Unis
-
Weill Medical College of Cornell UniversityBD2 LLCPas encore de recrutementIRMf | Trouble bipolaire (TB) | SMTr | Dépression bipolaire 1États-Unis
-
Xentria, Inc.Pas encore de recrutement
-
Yale UniversityNational Institute of Mental Health (NIMH)Pas encore de recrutement
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRecrutementPhéochromocytome | Phéochromocytome/Paragangliome | Phéochromocytome métastatique | Phéochromocytome malin | Phéochromocytome et paragangliome (PPGL)Royaume-Uni
-
Carl Zeiss Meditec-Dublin CoCeRecrutementMembrane épirétinienne | Maladie de la rétine | Dégénérescence maculaire liée à l'âge sec | Anomalie vitréorétinienne | Macular Abnormalities | Intraretinal Hyporeflective Space | Subretinal Hyporeflective Space | IS/OS (Ellipsoid Zone) Disruption | Retinal Pigment Epithelium (RPE) Elevation | Retinal...États-Unis
-
Celest Therapeutics (Shanghai) Co., Ltd.The First Affiliated Hospital of Anhui Medical UniversityRecrutementCLDN18.2 Tumeurs solides positivesChine